Research & Development News

March 30, 2011	The New England Journal of Medicine Publishes Pivotal Studies Showing Potential of New Investigational Treatment for Chronic Infection with Hepatitis C Virus Genotype 1
November 18, 2010	In Phase III Study Merck's Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with coronary heart disease (CHD)
October 5, 2010	Canadians With Asthma Consider Their Disease 'Well Controlled' Despite Severe Episodes According To A New Survey
October 5, 2010	Backgrounder - Asthma In Canada And Survey
August 11, 2010	Merck Reports that Two Pivotal Phase III Registration Studies for Boceprevir Have Been Completed and Meet the Primary Endpoints

This site is for residents of Canada. / This site was updated on October 26, 2011.